APO RESEARCH · REPORT
Total Artificial Heart
Total Artificial Heart (TAH) is a prosthetic device that is implanted into the body to replace the biological heart. A few proprietary artificial heart devices have been developed including the Syncardia TAH, AbioCor (Abiomed, Danvers, Massachusetts, USA), and CARMAT (Carmat, Velizy, France). The history of these devices and their clinical use has recently been reviewed. Among the devices listed, the Syncardia (TAH) is the only device currently in use. The CARMAT is currently undergoing feasibility studies, however, data has been limited to a handful of patients thus far. There is also no data on the use of the AbioCor or CARMAT in patients with CHD.
Product & engineering
Understand the product.
Total Artificial Heart (TAH) is a prosthetic device that is implanted into the body to replace the biological heart. A few proprietary artificial heart devices have been developed including the Syncardia TAH, AbioCor (Abiomed, Danvers, Massachusetts, USA), and CARMAT (Carmat, Velizy, France). The history of these devices and their clinical use has recently been reviewed. Among the devices listed, the Syncardia (TAH) is the only device currently in use. The CARMAT is currently undergoing feasibility studies, however, data has been limited to a handful of patients thus far. There is also no data on the use of the AbioCor or CARMAT in patients with CHD.
Selected research
Industry Research
Total Artificial Heart Industry Research Report 2026
Market perspective
Total Artificial Heart (TAH) is a prosthetic device that is implanted into the body to replace the biological heart. A few proprietary artificial heart devices have been developed including the Syncardia TAH, AbioCor (Abiomed, Danvers, Massachusetts, USA), and CARMAT (Carmat, Velizy, France). The history of these devices and their clinical use has recently been reviewed. Among the devices listed, the Syncardia (TAH) is the only device currently in use. The CARMAT is currently undergoing feasibility studies, however, data has been limited to a handful of patients thus far. There is also no data on the use of the AbioCor or CARMAT in patients with CHD.
Global Total Artificial Heart key players include only SynCardia, with a share about 100%. North America is the largest market, with a share about 60%, followed by Europe, with a share about 40 percent. In terms of product, SynCardia is the largest segment, with a share about 100%. And in terms of application, the largest application is Ischemic Cardiomyopathy, followed by Dilated Cardiomyopathy, etc.
Report Scope
Read the full market overview
This report quantifies the global Total Artificial Heart market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Total Artificial Heart Market by Company
BiVACOR
SynCardia
Jarvik Heart
CARMAT
AbioMed
Total Artificial Heart Segment by Type
SynCardia
Others
Total Artificial Heart Segment by Application
Dilated Cardiomyopathy
Ischemic Cardiomyopathy
Others
Total Artificial Heart Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Total Artificial Heart market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Total Artificial Heart and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Total Artificial Heart.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Total Artificial Heart manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Total Artificial Heart by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Total Artificial Heart in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- SynCardia
- Others
Applications
- Dilated Cardiomyopathy
- Ischemic Cardiomyopathy
- Others
Companies covered
- BiVACOR
- SynCardia
- Jarvik Heart
- CARMAT
- AbioMed
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Total Artificial Heart Market Size (2021-2032)
- 2.2.2 Global Total Artificial Heart Sales (2021-2032)
- 2.2.3 Global Total Artificial Heart Market Average Price (2021-2032)
- 2.3 Total Artificial Heart by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 SynCardia
- 2.3.3 Others
- 2.4 Total Artificial Heart by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Dilated Cardiomyopathy
- 2.4.3 Ischemic Cardiomyopathy
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Total Artificial Heart Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Total Artificial Heart Sales (Units) of Manufacturers (2021-2026)
- 3.3 Global Total Artificial Heart Revenue of Manufacturers (2021-2026)
- 3.4 Global Total Artificial Heart Average Price by Manufacturers (2021-2026)
- 3.5 Global Total Artificial Heart Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Total Artificial Heart, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Total Artificial Heart, Product Type & Application
- 3.8 Global Manufacturers of Total Artificial Heart, Established Date
- 3.9 Global Total Artificial Heart Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 BiVACOR
- 4.1.1 BiVACOR Company Information
- 4.1.2 BiVACOR Business Overview
- 4.1.3 BiVACOR Total Artificial Heart Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 BiVACOR Total Artificial Heart Product Portfolio
- 4.1.5 BiVACOR Recent Developments
- 4.2 SynCardia
- 4.2.1 SynCardia Company Information
- 4.2.2 SynCardia Business Overview
- 4.2.3 SynCardia Total Artificial Heart Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 SynCardia Total Artificial Heart Product Portfolio
- 4.2.5 SynCardia Recent Developments
- 4.3 Jarvik Heart
- 4.3.1 Jarvik Heart Company Information
- 4.3.2 Jarvik Heart Business Overview
- 4.3.3 Jarvik Heart Total Artificial Heart Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Jarvik Heart Total Artificial Heart Product Portfolio
- 4.3.5 Jarvik Heart Recent Developments
- 4.4 CARMAT
- 4.4.1 CARMAT Company Information
- 4.4.2 CARMAT Business Overview
- 4.4.3 CARMAT Total Artificial Heart Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 CARMAT Total Artificial Heart Product Portfolio
- 4.4.5 CARMAT Recent Developments
- 4.5 AbioMed
- 4.5.1 AbioMed Company Information
- 4.5.2 AbioMed Business Overview
- 4.5.3 AbioMed Total Artificial Heart Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 AbioMed Total Artificial Heart Product Portfolio
- 4.5.5 AbioMed Recent Developments
5 Global Total Artificial Heart Market Scenario by Region
- 5.1 Global Total Artificial Heart Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Total Artificial Heart Sales by Region: 2021-2032
- 5.2.1 Global Total Artificial Heart Sales by Region: 2021-2026
- 5.2.2 Global Total Artificial Heart Sales by Region: 2027-2032
- 5.3 Global Total Artificial Heart Revenue by Region: 2021-2032
- 5.3.1 Global Total Artificial Heart Revenue by Region: 2021-2026
- 5.3.2 Global Total Artificial Heart Revenue by Region: 2027-2032
- 5.4 North America Total Artificial Heart Market Facts & Figures by Country
- 5.4.1 North America Total Artificial Heart Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Total Artificial Heart Sales by Country (2021-2032)
- 5.4.3 North America Total Artificial Heart Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Total Artificial Heart Market Facts & Figures by Country
- 5.5.1 Europe Total Artificial Heart Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Total Artificial Heart Sales by Country (2021-2032)
- 5.5.3 Europe Total Artificial Heart Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Total Artificial Heart Market Facts & Figures by Country
- 5.6.1 Asia Pacific Total Artificial Heart Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Total Artificial Heart Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Total Artificial Heart Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Total Artificial Heart Market Facts & Figures by Country
- 5.7.1 South America Total Artificial Heart Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Total Artificial Heart Sales by Country (2021-2032)
- 5.7.3 South America Total Artificial Heart Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Total Artificial Heart Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Total Artificial Heart Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Total Artificial Heart Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Total Artificial Heart Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Total Artificial Heart Sales by Type (2021-2032)
- 6.1.1 Global Total Artificial Heart Sales by Type (2021-2032) & (Units)
- 6.1.2 Global Total Artificial Heart Sales Market Share by Type (2021-2032)
- 6.2 Global Total Artificial Heart Revenue by Type (2021-2032)
- 6.2.1 Global Total Artificial Heart Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Total Artificial Heart Revenue Market Share by Type (2021-2032)
- 6.3 Global Total Artificial Heart Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Total Artificial Heart Sales by Application (2021-2032)
- 7.1.1 Global Total Artificial Heart Sales by Application (2021-2032) & (Units)
- 7.1.2 Global Total Artificial Heart Sales Market Share by Application (2021-2032)
- 7.2 Global Total Artificial Heart Revenue by Application (2021-2032)
- 7.2.1 Global Total Artificial Heart Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Total Artificial Heart Revenue Market Share by Application (2021-2032)
- 7.3 Global Total Artificial Heart Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Total Artificial Heart Value Chain Analysis
- 8.1.1 Total Artificial Heart Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Total Artificial Heart Production Mode & Process
- 8.2 Total Artificial Heart Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Total Artificial Heart Distributors
- 8.2.3 Total Artificial Heart Customers
9 Global Total Artificial Heart Analyzing Market Dynamics
- 9.1 Total Artificial Heart Industry Trends
- 9.2 Total Artificial Heart Industry Drivers
- 9.3 Total Artificial Heart Industry Opportunities and Challenges
- 9.4 Total Artificial Heart Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst